Press releases
- Dexcom Announces Upcoming Conference Presentation
- Dexcom Announces Upcoming Conference Presentations
- Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time
- Dexcom Reports First Quarter 2022 Financial Results
- DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More Choice to People With Diabetes
- Dexcom Publishes Annual Sustainability Report
- Dexcom Announces Dexcom ONE, the Newest Real-Time Continuous Glucose Monitoring System, to Its Range of Scan-Free and Fingerprick†-Free Devices
- Dexcom Schedules First Quarter 2022 Earnings Release and Conference Call for April 28, 2022 at 4:30 p.m. Eastern Time
- Dexcom Announces Four-for-One Forward Stock Split
- Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management
More ▼
Key statistics
As of last trade Dexcom Inc (DC4:STU) traded at 302.55, 5.02% above its 52-week low of 288.10, set on May 26, 2021.
52-week range
Markit short selling activity
Open | 307.50 |
---|---|
High | 307.50 |
Low | 302.55 |
Bid | 301.65 |
Offer | 304.80 |
Previous close | 301.70 |
Average volume | 170.20 |
---|---|
Shares outstanding | 98.13m |
Free float | 97.73m |
P/E (TTM) | 158.42 |
Market cap | 31.78bn USD |
EPS (TTM) | 2.04 USD |
Data delayed at least 15 minutes, as of May 23 2022.
More ▼